comparemela.com

Latest Breaking News On - Perceptive advisors - Page 11 : comparemela.com

Insider Selling: Edgewise Therapeutics, Inc (NASDAQ:EWTX) CEO Sells 3,152 Shares of Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) CEO Kevin Koch sold 3,152 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of $18.91, for a total transaction of $59,604.32. Following the sale, the chief executive officer now directly owns 14,478 shares in the […]

Brokerages Set Viridian Therapeutics, Inc (NASDAQ:VRDN) PT at $36 60

Brokerages Set Viridian Therapeutics, Inc (NASDAQ:VRDN) PT at $36 60
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Nuvalent, Inc (NASDAQ:NUVL) Director Matthew Shair Sells 2,000 Shares

Nuvalent, Inc. (NASDAQ:NUVL – Get Free Report) Director Matthew Shair sold 2,000 shares of the business’s stock in a transaction that occurred on Monday, April 29th. The stock was sold at an average price of $67.51, for a total transaction of $135,020.00. Following the sale, the director now directly owns 236,522 shares of the company’s […]

Edgewise Therapeutics (NASDAQ:EWTX) Trading 6 3% Higher

Edgewise Therapeutics (NASDAQ:EWTX) Trading 6 3% Higher
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Autolus Therapeutics (NASDAQ:AUTL) Sees Unusually-High Trading Volume

Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 5,489,741 shares changed hands during trading, an increase of 238% from the previous session’s volume of 1,624,192 shares.The stock last traded at $3.79 and had previously closed at $3.68. Analyst Upgrades and Downgrades AUTL has been the […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.